Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R G Hahn

Showing results (241-250 of 368) with videos related to

Pageof 37
Sort By:
European Urology|January 1, 1997
Blood haemoglobin and the long-term incidence of acute myocardial infarction after transurethral resection of the prostateR G Hahn, A Nilsson, B Y Farahmand, et al.
The New England Journal of Medicine|February 20, 1992
Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinomaC G Moertel, M Lefkopoulo, S Lipsitz, et al.
Cancer Treatment Reports|April 1, 1983
Phase II study of maytansine in advanced sarcomasJ H Edmonson, R G Hahn, E T Creagan, et al.
Cancer Treatment Reports|April 1, 1980
Phase II study in advanced sarcoma: randomized trial of pyrazofurin versus combination cyclophosphamide, doxorubicin, and cis-dichlorodiammineplatinum(II) (CAP)W J Cormier, R G Hahn, J H Edmonson, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|November 1, 1994
Eating a meal increases the clearance of ethanol given by intravenous infusionR G Hahn, A Norberg, J Gabrielsson, et al.
Oncology|January 1, 1977
A clinical trial adriamycin (NSC 123127) in advanced sarcomasE T Creagan, R G Hahn, D L Ahmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1987
Phase II clinical trial of triazinate in combination with mitomycin C for patients with advanced gastric cancerM J O'Connell, A J Schutt, C G Moertel, et al.
Cancer Chemotherapy Reports|October 1, 1972
Phase II study of 5-azacytidine (NSC-102816) in the treatment of advanced gastrointestinal cancerC G Moertel, A J Schutt, R J Reitemeier, et al.
Cancer Chemotherapy Reports|February 1, 1972
Phase II study of camptothecin (NSC-100880) in the treatment of advanced gastrointestinal cancerC G Moertel, A J Schutt, R J Reitemeier, et al.
Cancer Chemotherapy Reports|June 1, 1971
Phase II study of strepozotocin (NSC-85998) in the treatment of advanced gastrointestinal cancerC G Moertel, R J Reitemeier, A J Schutt, et al.
Pageof 37

Showing results (241-250 of 368) with videos related to

Sort By:
Pageof 37
European Urology|January 1, 1997
Blood haemoglobin and the long-term incidence of acute myocardial infarction after transurethral resection of the prostateR G Hahn, A Nilsson, B Y Farahmand, et al.
The New England Journal of Medicine|February 20, 1992
Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinomaC G Moertel, M Lefkopoulo, S Lipsitz, et al.
Cancer Treatment Reports|April 1, 1983
Phase II study of maytansine in advanced sarcomasJ H Edmonson, R G Hahn, E T Creagan, et al.
Cancer Treatment Reports|April 1, 1980
Phase II study in advanced sarcoma: randomized trial of pyrazofurin versus combination cyclophosphamide, doxorubicin, and cis-dichlorodiammineplatinum(II) (CAP)W J Cormier, R G Hahn, J H Edmonson, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|November 1, 1994
Eating a meal increases the clearance of ethanol given by intravenous infusionR G Hahn, A Norberg, J Gabrielsson, et al.
Oncology|January 1, 1977
A clinical trial adriamycin (NSC 123127) in advanced sarcomasE T Creagan, R G Hahn, D L Ahmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1987
Phase II clinical trial of triazinate in combination with mitomycin C for patients with advanced gastric cancerM J O'Connell, A J Schutt, C G Moertel, et al.
Cancer Chemotherapy Reports|October 1, 1972
Phase II study of 5-azacytidine (NSC-102816) in the treatment of advanced gastrointestinal cancerC G Moertel, A J Schutt, R J Reitemeier, et al.
Cancer Chemotherapy Reports|February 1, 1972
Phase II study of camptothecin (NSC-100880) in the treatment of advanced gastrointestinal cancerC G Moertel, A J Schutt, R J Reitemeier, et al.
Cancer Chemotherapy Reports|June 1, 1971
Phase II study of strepozotocin (NSC-85998) in the treatment of advanced gastrointestinal cancerC G Moertel, R J Reitemeier, A J Schutt, et al.
Pageof 37